The Technology Transfer, sitting at the AO Innovation Translation Center (AO ITC), advances innovation to improve patient care and surgeon education in musculoskeletal disorders, by translating in-house and external technologies from bench to bedside.
Responsible for the funding streams of the Development Incubator and Strategy Fund, the Technology Transfer is your one-stop shop providing multiyear investments as well as support to secure intellectual property, develop regulatory strategies, gain access to manufacturers, and connect you with the largest network of trauma and orthopedic health care professionals in the world.
The AO funds innovation in a number of ways
Strategy Fund seed funding aimed for innovative products, services, and technologies improving surgeon education or any element of the entire patient journey in musculoskeletal disorders
Early stage idea?
Development Incubator to support inventors from proof of concept to clinical implementation, mentored by an independent board with expertise in R&D, financing, clinical validation, manufacturing, and industrialization
Developing solutions toward clinical implementation?
Strategy FundJune 12, 2019
Real reach, lasting impactAO Strategy Fund: Five years of success stories
Development IncubatorApril 08, 2019
Biphasic plateAO Development Incubator-supported biphasic plate promotes fast and robust fracture healing
Development IncubatorFebruary 01, 2019
AO Development Incubator Success StoriesAO Development Incubator supports ORS business innovation competition
You might also be interested in
"As part of the AO Innovation Translation Center, the Technology Transfer office offers an opportunity for inventors to take vital steps toward applying their ideas to advance patient care."
Michael Schütz, Chair, Technology Transfer Board, AO ITC